Tracon Raises Bridge

Tracon Pharmaceuticals Inc., a San Diego-based oncology drug company, has raised $9.5 million in senior convertible note financing, according to a regulatory filing. The deal was placed by Tracon backer Paramount Biosciences. www.traconpharma.com